Vakaramoko Diaby

Multi-criteria decision analysis (MCDA) in health care: A bibliometric analysis

Vakaramoko Diaby, Kaitryn Campbell, Ron Goeree · Operations Research for Health Care · 2013 · 175 citations

Nursing, Medical Decision Making, Primary Care +12

Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial

Vakaramoko Diaby, Georges Adunlin, Alberto J. Montero · PharmacoEconomics · 2013 · 141 citations

Prognostic Evaluation, Health Policy, Health Economics +11

Sedative-Hypnotic Medicines and Falls in Community-Dwelling Older Adults: A Cost-Effectiveness (Decision-Tree) Analysis from a US Medicare Perspective

Cara Tannenbaum, Vakaramoko Diaby, Sylvie Perreault et al. · Drugs & Aging · 2015 · 70 citations

Harm Reduction, Health Policy, Geriatrics +13

Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States

Vakaramoko Diaby, Georges Adunlin, Askal Ayalew Ali et al. · Breast Cancer Research and Treatment · 2016 · 47 citations · Full text

Breast Oncology, Cost-effectiveness Analysis, Line Sequential +6

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data

Nita A. Limdi, Larisa H. Cavallari, Craig R. Lee et al. · The Pharmacogenomics Journal · 2020 · 43 citations · Full text

Thrombosis, Percutaneous Coronary Intervention, Cyp2c19-guided Antiplatelet Therapy +12